Rebalix
Logo UBSUBS · sheet of 10 September 2026
ETF sheet · official issuer and register data

UBS MSCI USA Select Factor Mix UCITS ETF hEUR acc

IE00BDGV0746 · IE00BDGV0746 · EUR · domicile Ireland
Equity · United States · MultifattorialeEUR-hedged share classSFDR art. 6
Index tracked: MSCI USA Select Factor Mix 100% hedged to EUR (Net Return)
TER
0.28%+ trans. 0.00%
Fund size
8 m EUR
Tracking difference
+0.06%3-year avg
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical (full replication)
Income
Accumulating
Launch 6 Sept 2017 · costs from the KID as of 2 Sept 2026 · 1,970 securities held · 1 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 5 Aug 2026
The Fund is passively managed and seeks to track performance of the MSCI USA Select Factor Mix 100% hedged to EUR Index (Net Return) (the 'Index'). The Index is an alternatively weighted Index, being an Index whose constituents are weighted according to specific factors other than the size of the underlying constituent (measured by the market capitalization), that is based on its parent Index the MSCI USA IMI Index and captures large-, mid- and small-cap representation across the US equity markets. The parent Index the MSCI USA IMI Index is constructed…

Performance since series start (in euro) — base 100

6 Sept 20178 Sept 2026 · dividends reinvested where declared by the issuer
2018202020222024202624786242
High 247 (17 Aug 2026) · low 86 (20 Mar 2020) · last 242. Past performance is not indicative of future results.

Returns in euro

1 year+17.5%
3 years+55.7%
5 years+43.7%
10 yearsseries too young
Since series start+142.4%

Risk · 1 / 3 / 5 years

Volatility (ann.)11.38%13.12%15.41%
Max drawdown−8.08%−16.18%−24.05%
Sharpe1.290.960.40
Sortino1.921.410.56
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · IE00BDGV0746 · IE00BDGV07461
RebalixIE00BDGV0746 · IE00BDGV0746 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+10.53%+10.52%+0.00%
2024+16.26%+16.22%+0.04%
2023+13.13%+13.00%+0.13%
2022−16.10%−16.19%+0.09%
2021+22.61%+22.63%−0.03%

Holdings

Portfolio as declared by the issuer · 19 Aug 2026 · 1,970 securities · top-10 weight = 12.8%
Top holdingsWeight
JOHNSON & JOHNSON2.0%
APPLE INC1.6%
LAM RESEARCH CORP1.5%
VISA INC-CLASS A SHARES1.4%
WALMART INC1.3%
MERCK & CO. INC.1.2%
MICRON TECHNOLOGY INC1.0%
BERKSHIRE HATHAWAY INC-CL B1.0%
ELI LILLY & CO1.0%
CATERPILLAR INC1.0%
Sectors (% of fund)
Informatica22.4%Finanza17.0%Industriali14.4%Salute13.0%Beni di prima necessita'7.5%

Listing venues

ESMA register (FIRDS) and official exchange lists
USMUFE · Borsa Italiana (ETFplus)
+ 4 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.ubs.com/2/e/priip/PRIIPSEU_IE00BDGV0746_en_IE.pdf
Factsheet · www.ubs.com/2/e/files/RET/FS_RET_IE00BDGV0746_IT_IT.pdf
Prospectus · www.ubs.com/2/e/files/ubs_irl_etf_plc_peit.pdf
The live sheet, always up to date
rebalix.com/en/etf/IE00BDGV0746
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · IE00BDGV0746 · IE00BDGV07462